The aim of this study was to evaluate the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in the erythrocytes of children with epilepsy. For this purpose, the activity of superoxide dismutase, glutathione peroxidase, and glutathione reductase and the malondialdehyde concentration in 61 healthy children and 90 children with epilepsy were measured. The activities of all of these enzymes were insignificantly higher, whereas the malondialdehyde concentration was significantly lower in the patients treated with carbamazepine monotherapy. In patients treated with valproate monotherapy, the activities of all enzymes were insignificantly lower, whereas the malondialdehyde concentration was insignificantly higher. In patients treated with polytherapy, the activity of superoxide dismutase was insignificantly lower, whereas the activity of glutathione peroxidase and glutathione reductase was insignificantly higher and the malondialdehyde concentration was lower. There were differences in glutathione reductase activity between the valproate monotherapy group and both the carbamazepine monotherapy and polytherapy groups and in malondialdehyde concentrations between the carbamazepine and valproate groups. The results indicate that the oxidant-antioxidant balance in children with epilepsy is modified by antiepileptic therapy. (J Child Neurol 2006;21:558—562; DOI 10.2310/7010.2006.00115).
Get full access to this article
View all access options for this article.
References
1.
Delanty N., Dichter MA: Oxidative injury in the nervous system. Acta Neurol Scand1998;98:145—153.
2.
Choi BH: Oxygen, antioxidants and brain dysfunction. Yonsei Med J1993;34:1—10.
3.
Frantseva MV, PerezValazquez JL, Tsorakkidis G., et al: Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience2000;97:431—435.
Ben-Menachem E., Kyllerman M., Marklund S.: Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res2000;40:33—39.
8.
Sobaniec W., Kulak W., Sobaniec H., et al: Effects of clobazam and vitamin E on the lipid peroxidation in the rat brain after electroconvulsive shock. Ann Acad Med Bialtstok1999;44:134—140.
9.
Ono H., Sakamoto A., Sakura N.: Plasma total glutathione concentrations in epileptic patients taking anticonvulsants . Clin Chim Acta2000;298:135—143.
10.
Seckin S., Basaran-Kucukgergin C., Uysal M.: Effect of acute and chronic administration of sodium valproate on lipid peroxidation and antioxidant system in rat liver. Pharmacol Toxicol1999;85: 294—298.
11.
Wang JF, Azzam JE, Young LT: Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience2003 ;116:485—489.
12.
Sobaniec W. : Lipid peroxidation in experimental and clinical epilepsy and the effects of sodium valproate and vitamin E on these processes . Neuroscience1992;18:123—130.
13.
Mahle C., Dasgupta A.: Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci1997;61:437—443.
14.
Liu CS, Wu HM, Kao SH, Wei YH: Phenytoin-mediated oxidative stress in serum of female epileptics possible pathogenesis in the fetal hydantoin syndrome. Hum Exp Toxicol1997;16:177—181.
15.
Liu CS, Wu HM, Kao SH, Wei YH: Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy . Clin Neuropharmacol1998;21:62—64.
16.
Artemowicz B., Sołowiej E., Sobaniec W.: The disturbance of the oxidants-antioxidants balance in epileptic children. Int J Neuroprotec Neuroregen2004;1:27—31.
17.
Sobaniec W. , Kulak W., Bockowski L., et al: Studies of damages processes in the nervous system and possibilities of neuroprotectionPrzegl Lek2001;58:41—47.
18.
Solowiej E., Sobaniec W.: The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsyNeurol Neuroch Pol2003;37:991— 1003.
19.
Sykes JA, McCormack FX, O'Brien TJ: A preliminary study of superoxide dismutase content of some human tumors. Cancer Res1978;38:2759—2762.
20.
Paglia DE, Valentine WN: Study on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med1967 ;70:158—169.
21.
Mize CE, Langdon RG: Hepatic glutathione reductase I. Purification and general kinetic properties . J Biol Chem1962; 237:1589—1595.
22.
Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol1978;51:302—310.
23.
Pippenger CE, Meng X., Van Lente F, Rothner AD: Valproate therapy depresses GSH-Px and SOD enzyme activity. A possible mechanism for VPA induced idiosyncratic drug toxicity. Clin Chem1989;35:1173.
24.
Cengiz M., Yuksel A., Seven M.: The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol Res2000;41:423—425.
25.
Niketic V., Ristic S., Saicic ZS, et al: Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (HbASSG) in epileptic patients with long-term antiepileptic therapy. Farmacol1995;50:811—813.
26.
Kurekci AE, Alpay F., Tanindi S., et al: Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy . Epilepsia1995;36:600—604.
27.
Verrotti A. , Basciani F., Trotta D., et al: Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res2002;48:71—75.
28.
Cotariu D., Evans S., Lahat E., et al: Inhibition of human red blood cell glutathione reductase by valproic acid. Biochem Pharmacol1992;43:425—429.
29.
Yuksel A., Cengiz M., Seven M., Ulutin T.: Erythrocyte glutathione peroxidase, superoxidase dismutase and serum lipid peroxidation in epileptic children valproate and carbamazepine monotherapy . J Basic Clin Physiol Pharmacol2000;11:73—81.
30.
Yuksel A., Cengiz M., Seven M., Ulutin T.: Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: Two-year prospective studies. J Child Neurol2001;16:603—606.
31.
Graf WD, Oleinik OE, Glauser TA, et al: Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy. Neuropediatrics1998;29:195—201.
32.
Maertens P. , Dyken P., Graf W., et al: Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. Am J Med Genet1995;57:225—228.
33.
Martinez-Ballesteros C., Pita-Calandre E., Sanches-Gonzalez Y., et al: Lipid peroxidation in adult epileptic patients treated with valproic acid. Rev Neurol2004;38:101—106.
34.
Cardile V., Pavone A., Renis M., et al: Biological effects of tiagabine on primary cortical astrocyte cultures of rat. Neurosci Lett2000; 288:49—52.
35.
Bashkatova VG, Vitskova G., Narkevich VB, et al: The effect of anticonvulsants on the nitric oxide content and level of lipid peroxidation in the brain of rats in model seizure states. Eksp Klin Farmakol1999;62:11—14.
36.
Pavone A., Cardile V.: An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia2003;44:34—39.
